10 Most Profitable Growth Stocks to Buy

7. Globus Medical Inc. (NYSE:GMED)

TTM Net Income: $586 million

Globus Medical Inc. (NYSE:GMED) is one of the most profitable growth stocks to buy. On May 7, Globus Medical reported a strong start to 2026, with worldwide net sales reaching $759.9 million for Q1, representing a 27.0% increase. The company’s core spine business and enabling technologies drove organic revenue growth of 13.2%, while GAAP net income rose to $124.3 million. Diluted EPS saw significant gains, with GAAP EPS reaching $0.90 and non-GAAP EPS hitting $1.12.

Leadership attributed this success to disciplined manufacturing, supply chain initiatives, and structural cost management, which fueled margin expansion. The US spine division maintained a steady growth trajectory, marking its third consecutive quarter of 10% year-over-year growth. Meanwhile, the integration of the recently acquired Nevro business continues to proceed as expected.

Following these results, Globus Medical Inc. (NYSE:GMED) has reaffirmed its full-year 2026 revenue guidance of $3.18 billion to $3.22 billion. Due to strong performance, the company updated its non-GAAP fully diluted EPS outlook, raising the projected range to $4.70-$4.80 from its previous guidance of $4.40-$4.50.

Globus Medical Inc. (NYSE:GMED) is a medical device company involved in the development and commercialization of healthcare solutions. The company classifies its products into Innovative Fusion and Disruptive Technology, and operates through the US and International geographical segments.